Carole Auger

PhD
UniversitéLyon1-INSERM, UMR-S1028
Lyon Neuroscience Research Center, Oncoflam Team,
Papers:
BKM120, a pure PI3K inhibitor, demonstrates stronger anti tumoral effect than BEZ235, a dual PI3K-mTOR inhibitor, on rat prolactin secreting pituitary tumor SMtTW-3